Top Factor Driving Allogeneic Cell Therapy Market Growth in 2025: Allogeneic Cell Therapy Revolutionizing The Treatment Of Chronic Illnesses

How Big Is the Allogeneic Cell Therapy Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the allogeneic cell therapy market has experienced swift expansion. The market, poised to increase from $1.08 billion in 2024, is projected to reach $1.2 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.9%. The growth observed in the historic period can be credited to heightened attention towards tailoring donor cell selection and genetic modifications, a rising populace, a global increase in ongoing chronic diseases, heightened awareness, and an increment in partnerships for biosimilar development.

Forecasts suggest a swift expansion for the allogeneic cell therapy market in the coming years, advancing to a size of $1.86 billion in 2029 with an annual compound growth rate (CAGR) of 11.5%. This growth during the projected period can be ascribed to numerous factors such as the enhanced need for state-of-the-art medical procedures, increasing consumer demand for innovative allogeneic cell therapies, a rising tally of clinical trials, a growing patient demographic, and higher income levels. In the coming forecast period, key trends to watch include technological advancements, strategic alliances, industry leaders teaming up with other big players, mergers and acquisitions, and product launches.

What Is Stimulating Growth in the Allogeneic Cell Therapy Market?
The escalating number of chronic disease cases is anticipated to be instrumental in driving the allogeneic cell therapy market's growth. Chronic conditions are enduring ailments that typically necessitate consistent medical care and potentially affect everyday activities or one's quality of life. The rise of chronic diseases can be attributed to changes in lifestyle habits, genetic inheritance, as well as exposure to chemicals, toxins, and pollutants. Allogeneic cell therapy, which uses healthy cells from a donor to modulate, replace, or mend dysfunctional cells or tissues in a patient, is incredibly potent in treating an array of chronic diseases. As an example, in January 2023, the National Center for Biotechnology Information (NCBI), a medicine library based in the US, projected a 99.5% surge in the number of individuals aged 50 and over suffering from at least one chronic ailment, numbering from 71.52 million in 2020 to 142.66 million by 2050. Hence, the rising incidence of chronic diseases propels the growth of the allogeneic cell therapy market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

Who Are the Dominant Companies Influencing Allogeneic Cell Therapy Market Trends?
Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

How Is the Allogeneic Cell Therapy Market Evolving?
Key players in the allogeneic cell therapy market are concentrating on the creation of novel solutions such as cell processing platforms, in an effort to consolidate their market presence. Cell processing platforms are systems and processes used for the preparation and management of cells for therapeutic uses, incorporating isolation, purification, expansion, modification, and quality control to confirm cells are fit for clinical applications. For example, Getinge, a healthcare company from Sweden, and CellRev, a biotechnology company based in the UK, teamed up in March 2024 to introduce Livit ACE, a continuous cell processing (Adherent Cell Expansion) platform. This ground-breaking platform merges advanced automation with bioprocessing technologies, considerably boosting the productivity and scalability of cell manufacturing. It comes with unique attributes such as top-notch cell isolation and purification systems that guarantee elevated cell purity and viability, sturdy expansion faculties to generate abundant therapeutic cells, intricate genetic modification mechanisms for accurate cell engineering, and strict quality control strategies to ensure the cell products' safety and efficacy.

What Are the Different Segmentations in the Allogeneic Cell Therapy Market?
The allogeneic cell therapy market covered in this report is segmented -

1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies
2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders, Other Therapeutic Area
3) By End User: Hospitals, Specialty Clinics, Research Organizations

Subsegments:
1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy, Other Stem Cell Therapies
2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies, Other Non-Stem Cell Therapies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

Which Region Is at the Forefront of the Allogeneic Cell Therapy Market?
North America was the largest region in the allogeneic cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Allogeneic Cell Therapy Global Market Report?

- Market Size Analysis: Analyze the Allogeneic Cell Therapy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Allogeneic Cell Therapy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Allogeneic Cell Therapy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Allogeneic Cell Therapy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15976

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.